Arecor Therapeutics (AREC.LSE) Q3 2024 Earnings

26SepConfirmed
Q1 2023
Q2 2023
Q2 2024
Q3 2024
-14.14
-13.81
-13.48
-13.14

Details

Expected EPS
N/A
Actual EPS
-14.1437241
Surprise EPS
-14.14
Surprise Percent
+∞%

Description

Arecor Therapeutics (AREC.LSE) has reported earnings of -14.1437241 per share for Q3 2024.

0 Comments

Share your thoughts